Einstein researchers develop novel antibiotics that don't trigger resistance

Bacterial resistance to antibiotics is one of medicine's most vexing challenges. In a study described in Nature Chemical Biology, researchers from Albert Einstein College of Medicine of Yeshiva University are developing a new generation of antibiotic compounds that do not provoke bacterial resistance. The compounds work against two notorious microbes: Vibrio cholerae, which causes cholera; and E. coli 0157:H7, the food contaminant that each year in the U.S. causes approximately 110,000 illnesses and 50 deaths.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news156174057.html">Einstein researchers develop novel antibiotics that don't trigger resistance</a></p> <p>Bacterial resistance to antibiotics is one of medicine's most vexing challenges. In a study described in <I>Nature Chemical Biology,</I> researchers from Albert Einstein College of Medicine of Yeshiva University are developing a new generation of antibiotic compounds that do not provoke bacterial resistance. The compounds work against two notorious microbes: <I>Vibrio cholerae,</I> which causes cholera; and <I>E. coli</I> 0157:H7, the food contaminant that each year in the U.S. causes approximately 110,000 illnesses and 50 deaths.</p>